Susan Mieko Afuso Fujita

Susan M.A. Fujita serves as a Contract Specialist responsible for managing the acquisition lifecycle for complex medical and surgical equipment procurements. She plays a critical role in ensuring compliance with federal acquisition regulations while aligning purchasing decisions with mission-critical healthcare needs. Her portfolio primarily encompasses the procurement of diagnostic instruments, surgical supplies, electromedical devices, and pharmaceutical preparations, requiring deep technical understanding of FDA-regulated products and quality assurance standards. Fujita executes full-cycle contracting actions—from market research and solicitation development to award and contract administration—ensuring transparency, competition, and regulatory integrity across all acquisitions. While specific contractor names are not disclosed, Fujita maintains a robust network of manufacturers and suppliers specializing in medical device production, including both large-scale industrial firms and niche innovators in surgical technology. Her contracting patterns reflect a preference for established vendors with proven compliance in Good Manufacturing Practices and ISO 13485 certification, alongside active engagement with small business suppliers meeting technical and regulatory thresholds. She fosters collaborative vendor relationships grounded in performance accountability and supply chain resilience. Fujita’s set-aside preferences are heavily skewed toward unrestricted competition, with 88.7% of acquisitions conducted without socioeconomic set-asides. However, she consistently supports small business participation, allocating 10.5% of awards to Total Small Business Set-Asides under FAR 19.5 and 0.8% to Service-Disabled Veteran-Owned Small Businesses. Her approach balances broad competition with targeted opportunities, demonstrating a measured yet intentional commitment to socioeconomic contracting goals. Her primary procurement focus lies in NAICS 339112 (Surgical and Medical Instrument Manufacturing), 325413 (In-Vitro Diagnostic Substance Manufacturing), and 339113 (Surgical Appliance and Supplies Manufacturing), reflecting deep expertise in Class II and III medical devices. She regularly evaluates technical specifications for sterilization, biocompatibility, and regulatory submissions, ensuring acquired products meet clinical and safety standards for use in healthcare environments.